Anticancer CAS 114977-28-5 Ifu ya Docetaxel API Ifu

Ibisobanuro bigufi:

Docetaxel ni igice cya sintetike ya API, kandi igisekuru cya kabiri cyo kurwanya kanseri API kiboneka hamwe na synthesis ya 10-DAB.Ubwinshi bwimitsi ya docetaxel bwikubye inshuro 3 kurenza ubwa paclitaxel, kandi igihe cyo kugumana imitsi ni kirekire, bityo gifite ibikorwa bya antitumor kurusha paclitaxel.Hande Bio numwuga wa docetaxel wumwuga kandi utanga isoko, atanga Anticancer CAS 114977-28-5 Ifu ya Docetaxel API Ifu.Kubindi bisobanuro, nyamuneka twandikire kumurongo.


Ibicuruzwa birambuye

Ibicuruzwa

Amakuru y'ibicuruzwa

Izina:Inyandiko

Numero ya CAS:114977-28-5

Imiti yimiti:C45H57NO14

Ibisobanuro:99%

Ibara:ifu yera

Inkomoko:Igice cya kabiri hamwe na 10-DAB

Ubwoko:APIs

Ubushobozi bwo gukora

Inzira y'ibicuruzwa:Iminsi 7.

Ubushobozi bwo gutanga umusaruro:hariho ibarura, hariho inzira, kandi umusaruro mwinshi birashoboka.

Serivisi zacu

1.Ibicuruzwa:Tanga ibihingwa byujuje ubuziranenge, bifite isuku nyinshi, ibikoresho bya farumasi, hamwe naba farumasi.

2.Serivisi za tekiniki:Ibicuruzwa byabigenewe bifite ibisobanuro byihariye ukurikije ibyo umukiriya asabwa.

Uruganda rwa Hande

Yunnan hande Biotechnology Co., Ltd., yashinzwe muri Kanama 1993, ni uruganda rukora ubuhanga buhanitse mu bushakashatsi no guteza imbere ibinyabuzima. Nyuma y’iterambere, hande yashyizeho uburyo bwiza, bugenzura ubuziranenge bw’ibicuruzwa hakurikijwe amahame yo hejuru, kandi yagabanije agaciro k'umusaruro w'ubushobozi bwo gukora.Ibicuruzwa byanyuze mu cyemezo cy'amategeko n'amabwiriza mpuzamahanga, kandi bihinduka uruganda rukora ibikoresho bibisi bituma buri wese yumva yisanzuye.

Uruganda

Ba umutanga mwiza wibikoresho fatizo ninganda zifite ubunyangamugayo!

Murakaza neza kundeba mwohereza imeri kurimarketing@handebio.com


  • Mbere:
  • Ibikurikira: